ArticlePLoS medicine2025

Frailty in randomized controlled trials of glucose-lowering therapies for type 2 diabetes: An individual participant data meta-analysis of frailty prevalence, treatment efficacy, and adverse events.

Heather Wightman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.